Penta Pharma Egypt is a dynamic generic pharmaceutical joint stock company based in Egypt with a diverse and experienced team. Our extensive generics portfolio, approved by the Egyptian Drug Authority (EDA), covers a diverse range of therapeutic areas. Manufacturing Excellence Our state-of-the-art manufacturing facility, located in Ismailia's Abu Sultan industrial zone, is the backbone of our commitment to quality. Specializing in solid and semi-solid preparations, our production lines adhere to the highest international standards. With an ambitious plan to add more production lines and introduce additional dosage forms, we continuously strive to expand our capabilities. Our manufacturing site received positive audits from the Ministry of Health and Population in Egypt and other countries in Africa and the Middle East, such as Iraq, Yemen, Sudan, Libya, and Congo. The site also received an ISO 9001 certification, showcasing our dedication to excellence. EDA-Approved Quality At Penta Pharma Egypt, we are committed to manufacturing and marketing the most updated portfolio of EDA-approved generic products. Our dedication to quality extends to having one of the largest generic pipelines in the region, ensuring a continuous supply of innovative and effective medications. Patient-Centric Approach Understanding the importance of making safe and quality medications accessible to all, we operate with a patient-centric approach. By prioritizing the needs of our patients, we aim to contribute to the well-being of individuals across Egypt and beyond. Your Healthcare Partner Penta Pharma Egypt is more than a pharmaceutical company; we are your healthcare partner. Together, let us navigate the path to better health and well-being.
| Website | http://www.pentapharma.com |
| Revenue | $17.9 million |
| Employees | 286 (142 on RocketReach) |
| Technologies |
Microsoft Office
,
Linux
,
Teamwork
+4 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmaceutical, Generics, Generic Drugs, Prescription Drugs, Pharmacy, Drugs, Healthcare, Therapeutics, Health, Medicine, Treatment, Medications, Joint Stock, Over The Counter, Otc |
| Competitors | GSK, Hikma Pharmaceuticals, EVA pharma, Marcyrl Pharmaceutical Industries, Amoun Pharmaceutical Industries Company, ADWIA Pharmaceuticals, ePharma, Deltapharma S.A, Specialized Pharma Analytics LLC, Droguería Zeta Pharma +6 more (view full list) |
| SIC | SIC Code 21 Companies, SIC Code 20 Companies |
| NAICS | NAICS Code 3122 Companies, NAICS Code 312 Companies, NAICS Code 31 Companies, NAICS Code 33 Companies |
Looking for a particular Pentapharma Egypt employee's phone or email?
The Pentapharma Egypt annual revenue was $17.9 million in 2026.
142 people are employed at Pentapharma Egypt.
The NAICS codes for Pentapharma Egypt are [3122, 312, 31, 33].
The SIC codes for Pentapharma Egypt are [21, 20].